If you did R&D work between 2022 and 2024 and your tax bills felt higher than they should have been, you weren’t imagining it. A lot of small business owners I’ve talked to recently have a vague sense that something changed with how they had to handle research and development costs, but they’re fuzzy on the details. Here’s the situation: a 2022 rule forced businesses to spread out their R&D deductions over five years instead of writing them off immediately. For many companies, that meant paying taxes on income that their R&D spending had already consumed. The good news is that rule has been reversed. The complicated news is that there’s a hard deadline, July 6, 2026, to go back and reclaim what you overpaid. And a lot of businesses are going to miss it.

What Changed, and Why It Matters Right Now

Before 2022, if your business spent money on qualifying research and development, you could deduct the full amount in the year you spent it. Simple. That changed starting with tax year 2022, when a provision in the tax code required businesses to amortize domestic R&D costs over five years instead. So if you spent $500,000 on qualifying R&D in 2023, you could only deduct $100,000 that year. The other $400,000 got spread out over the following four years. You paid taxes on income that was already gone.

The One Big Beautiful Bill Act, signed on July 4, 2025, retroactively reversed that rule. Under the new Section 174A, businesses can now claim 100% immediate expensing of domestic R&D costs. More importantly, the law made this change retroactive, covering 2022, 2023, and 2024. That means the tax you overpaid during those years can potentially come back to you, but only if you file amended returns before the window closes.

For a business with $500,000 in qualifying 2023 R&D expenses, the difference is enormous. Instead of deducting $100,000 per year, you can now amend that return to claim the full $500,000 at once. Depending on your tax rate, that could translate to a six-figure refund from a single amended filing. That’s real money, and it’s sitting out there unclaimed for a lot of small businesses right now.

Who Qualifies, and Is Your 2022 Return Already Gone?

Recommended Rollo USB Thermal Shipping Label Printer 4x6

Commercial-grade direct thermal label printer printing one 4x6 label per second, no ink required.

Check Price →
Tax YearOriginal Filing DeadlineAmended Return Window ClosesStatus for Most Small Businesses
2022 (S-corps/Partnerships)March 15, 2023March 15, 2026Already Closed
2023March 15, 2024March 15, 2027Open
2024March 15, 2025March 15, 2028Open
2022 (C-corporations)October 15, 2023October 15, 2026Open (but narrowing)

Helpful resource: Traction: Get a Grip on Your Business by Gino Wickman is a top-rated option for this. (As an Amazon Associate this site earns from qualifying purchases.)

You might be wondering whether your business is even eligible. The IRS defines “eligible small business” for purposes of this retroactive fix as companies with average annual gross receipts under $31 million across 2022 through 2024. If you’re under that threshold and you had genuine qualifying R&D expenditures during any of those years, you should be talking to someone about this immediately.

Here’s the thing I want you to pay attention to, because it catches people off guard. The deadline isn’t the same for every year. The July 6, 2026 date is the outer boundary set by IRS Revenue Procedure 2025-28, but the statute of limitations under Section 6511 applies independently to each tax year. For calendar-year partnerships and S-corporations that filed their 2022 returns by the March 15, 2023 deadline, that window closed on March 15, 2026. That one’s already gone for many businesses. As JLK Rosenberger noted in their March 2026 analysis, this timing gap is exactly where small businesses are getting tripped up: they hear about the July 6 date and assume all three years are still open, when in some cases 2022 is already off the table.

This is also why I’d push back against any instinct to wait until late June to start this process. The amended returns need to be prepared, reviewed, and filed. That takes time. If you’re a C-corporation that filed your 2022 return on October 15, 2023, you may still have that year available. If you’re an S-corp or partnership on a March 15 cycle, you likely don’t. You need to know which situation you’re in before you assume anything.

The Paperwork Is Simpler Than You’d Expect

Related video

How businesses manage money | Cashflow explained · Practical Wisdom - Interesting Ideas on YouTube

One thing that was genuinely holding businesses back before the OBBBA passed was the administrative burden of changing an accounting method. Normally, switching how you treat R&D costs would require filing Form 3115, which is a full accounting method change application. It’s not a casual form. It requires detailed documentation, IRS consent in some situations, and adds real complexity to the process.

The OBBBA waived that requirement entirely for this retroactive fix. According to CSSI Services’ 2026 R&D guidance, businesses only need to attach a brief election statement to the amended return. That’s a meaningful simplification. It doesn’t mean the process is trivial, but it does mean that the barrier to filing is lower than it might have been.

You still need to document that your expenses qualify as R&D under the tax code’s definitions. Not every business activity counts. The IRS looks for activities that involve technological uncertainty, experimentation, and development of new or improved products or processes. Software development, product prototyping, and certain engineering work often qualify. Consulting fees paid to a third party to do your bookkeeping don’t. A qualified tax professional can help you identify which costs actually meet the standard.

A Separate Opportunity Worth Knowing About

While we’re here, there’s another provision worth flagging for smaller businesses, even though it’s not affected by the July 6 deadline. If your company had less than $5 million in gross receipts, you may be eligible to offset R&D tax credits against your payroll taxes rather than your income tax liability. The OBBBA raised the annual cap on this offset to $500,000 per year, with a lifetime limit of $2.5 million.

This matters because many early-stage businesses don’t have much income tax liability to offset. The payroll tax offset is a way to actually monetize those credits even when you’re not yet profitable. It’s a different mechanism from the amended return opportunity, and the two can sometimes work together depending on your situation. As Strike Tax laid out in their 2026 field guide, understanding how these pieces interact is where a lot of value gets left on the table.

The Clock Is Real

Here’s what I tell people when they’re weighing whether to act on something like this: the cost of missing a hard deadline is permanent. You can always file next year’s return carefully. You can’t go back and claim a 2023 refund after the statute closes. If there’s any chance you had qualifying R&D expenses in 2022, 2023, or 2024, and your gross receipts were under $31 million, the math on getting a professional review done in the next few weeks is very straightforward.

Talk to a CPA or R&D tax specialist who’s familiar with the OBBBA changes. Be upfront that you’re working against a July 6 deadline. Bring whatever documentation you have on your research activities and related costs. This is not the time to DIY it or wait for a better moment. The deadline is the deadline, and for businesses that moved quickly, the refunds have been substantial.

Sources

This article is for general informational purposes only and does not constitute financial, tax, or legal advice. Business finance and tax rules vary by entity type, state, and individual circumstances. Consult a qualified CPA, enrolled agent, or business attorney for advice specific to your situation.

Disclosure: As an Amazon Associate, we earn a small commission from qualifying purchases at no extra cost to you. We only recommend products that genuinely support the topics covered in this article.